The invention provides compounds of Formula (I):
##STR1##
wherein: R1-R5, A, L, and X have any of the values
defined in the specification that are CCR-3 receptor antagonists, pharmaceutical
compositions containing them, methods for their use, and methods and intermediates
useful for preparing them.
